Mascoma Wealth Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-397
Closed -$11.3K – 485
2023
Q1
$11.3K Hold
397
– – ﹤0.01% 392
2022
Q4
$10.4K Hold
397
– – ﹤0.01% 404
2022
Q3
$9K Hold
397
– – ﹤0.01% 410
2022
Q2
$12K Hold
397
– – ﹤0.01% 396
2022
Q1
$10K Buy
+397
New +$9.83K ﹤0.01% 433

Other funds holding ALKS

Mascoma Wealth Management's ALKS Position: Q2 2023 in Review

Mascoma Wealth Management sold out of Alkermes (ALKS) in Q2 2023, closing a stake of 397 shares — an estimated $11.3K sold.

Mascoma Wealth Management first reported a position in ALKS in Q1 2022 and held it in 5 quarters. The position peaked at $12K in Q2 2022. 292 funds tracked by Wall St. Rank hold ALKS as of Q2 2023.

  • Mascoma Wealth Management reported no remaining Alkermes position as of Q2 2023 after selling out during the quarter.
  • Mascoma Wealth Management sold 397 Alkermes shares in Q2 2023, an estimated $11.3K.
  • Mascoma Wealth Management first reported a position in Alkermes in Q1 2022 and held it in 5 quarters.
  • Mascoma Wealth Management's Alkermes position peaked at $12K in Q2 2022.
  • 292 funds tracked by Wall St. Rank held Alkermes as of Q2 2023.

Based on Mascoma Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.